Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.

Accepted 2023-05-25 00:00:00 ET · period of report 2023-05-23 · accession 0001209191-23-032354 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-05-25	2023-05-23	TMCI	BAKEWELL JOHN K	Dir	A - Grant	$0.00	+2,753	5,048	+120%	$0
D	2023-05-25	2023-05-23	TMCI	BAKEWELL JOHN K	Dir	A - Grant	$0.00	+6,305	6,305	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-05-23	A	A	2,753	$0.00	5,048	D	—	—	(F1) Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the issuer's Common Stock issuable upon settlement of the RSUs until the earlier of (a) a change in control, (b) the Reporting Person's separation of service to the Issuer, or (c) the fifth anniversary of the RSU's grant date. (F2) Includes 2,753 RSUs.
2	Derivative	Stock Option (Right to Buy)	2023-05-23	A	A	6,305	$0.00	6,305	D	$26.34 · — to 2033-05-23	6,305 Common Stock	(F3) The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.